In this study, we analyzed two clinical datasets and found that low PGRMC1 and EGFR transcripts were associated with longer overall survival durations in HCC-bearing patients and that most patients expressing low PGRMC1 had low EGFR expression as well. This evidence concerns the gene PGRMC1 and hepatocellular carcinoma.